25-10-11T07:00:00+00:00","updated_at":null,"description":"$23","is_cfp_conf":null,"is_published":true,"accreditations":[{"id":17,"credit":6,"accreditation":{"id":1,"image":null,"title":"AMA PRA Category 1 Credit™","description":"The Binaytara is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara designates this live activity for a maximum of {credit} {title}. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to {credit} hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission."},"activity_number":"0686-0000-25-034-L01-P","additional_info":null},{"id":18,"credit":6,"accreditation":{"id":2,"image":null,"title":"Nursing Contact Hours","description":"Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for {credit} Contact Hours.\n"},"activity_number":"0686-0000-25-034-L01-P","additional_info":null},{"id":19,"credit":6,"accreditation":{"id":3,"image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/934db6aa-0a7e-4c1b-741f-1934a1e36e00/public","title":"ABIM MOC II","description":"Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to {credit} Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit."},"activity_number":"0686-0000-25-034-L01-P","additional_info":null},{"id":20,"credit":6,"accreditation":{"id":4,"image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/4f570da2-09d4-45b7-2ba3-751609b94100/Icon","title":"ACPE Pharmacy","description":"$24"},"activity_number":"0686-0000-25-034-L01-P","additional_info":null}],"additional_tax":null,"exhibitor_link":"https://www.sponsorships.binaytara.org/CDAHemeOnc","homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/241fc7d9-3940-4cda-e92c-2a54045baf00/thumbnail","additional_info":null,"target_audience":"

Hematologists/ Oncologists
Oncology Fellows
NPs/PAs
Pharmacists
Nurses

","meta_description":"","calculated_credit":null,"learning_objectives":"

Identify common molecular abnormalities across several prevalent malignancies and review the appropriate timing of testing to detect these abnormalities.
Interpret results of next-generation sequencing and other predictive biomarkers to assess responses to targeted therapies, while recognizing associated challenges.
Develop optimal molecular-targeted treatment strategies for the management of patients with cancer.
Summarize emerging research, mechanisms of action, and roles of novel molecular-targeted therapies in the clinical investigation of cancer patients.

","organizing_committee":"

Conference Chair

Arvind Chaudhry, MD, PhD

","price_additional_info":null,"accreditation_additonal_info":"\n"},"programData":[{"id":1754504621007,"title":"Updates in the management of Multiple Myeloma ","start":"2025-10-11T16:20:00.000Z","end":"2025-10-11T16:40:00.000Z","description":null,"raw_faculty":[{"id":62,"role":"faculty","uuid":"d519dd76-9db6-44a7-a64d-2887b6d3af82","conf_id":20,"faculty":{"id":1934,"bio":null,"dob":"1992-01-31T08:00:00+00

Conferences

Organizing Committee:

Target Audience:

Learning Objectives: